Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma. Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study

Cancer

Volumn 86, Issue 8, 1999, Pages 1470-1479

  Fukumoto, Mitsutaka ^a   Yoshida, Daisuke ^a   Hayase, Naoko ^a   Kurohara, Atsushi ^a   Akagi, Naoki ^a   Yoshida, Shoji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Lung carcinoma; Multidrug resistance; Prediction; Radioresistance; Single photon emission computed tomography; Technetium 99m; Tetrofosmin; Thallium 201

Indexed keywords

CISPLATIN; ETOPOSIDE; TECHNETIUM 99M; TETROFOSMIN; THALLIUM 201;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL VIABILITY; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG CARCINOMA; MALE; MULTIDRUG RESISTANCE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIVITY; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CISPLATIN; COMBINED MODALITY THERAPY; DRUG RESISTANCE, MULTIPLE; DRUG THERAPY; FEMALE; HUMANS; KINETICS; LUNG NEOPLASMS; MALE; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 0033569817     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1470::AID-CNCR13>3.0.CO;2-S     Document Type: Article

References (48)

1. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976;451:152-62.
2. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transport gene in a multidrug-resistant human lung cancer cell line. Science 1992;258:1650-4.
3. Kartner N, Riordan JR, Ling V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 1983;221:1285-8.
4. Shimm DS. Radiation resistance in a multidrug resistant human T-cell leukemia line, Int J Radiat Oncol Biol Phys 1988;15:931-6.
5. Tatu CA, Pauneascu V, Staneascu DI, Schneider F. P-glycoprotein mediated multidrug resistance assessment by flow cytometry in malignant hemopathies. Anticancer Res 1997; 17:2583-6.
6. Liu B, Sun D, Xia W, Hung MC, Yu D. Cross-reactivity of C219 anti-p170 (mdr-1) antibody with p185 (c-erbB2) in breast cancer cells: cautions on evaluating p170 (mdr-1). J Natl Cancer Inst 1997;89:1524-9.
7. Pall G, Spitaler M, Hofmann J, Thaler J, Ludescher C. Multidrug resistance in acute leukemia: a comparison of different diagnostic methods. Leukemia 1997;11:1067-72.
8. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 1996;37:1578-82.
9. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993;53:977-84.
10. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994;35:510-5.
11. 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes. Eur J Biochem 1998;252:140-6.
12. Moretti JL, Duran CM, Starzec A, de Beco V, Vergote J, Benazzouz F, et al. Involvement of glutathione in loss of technetium-99m-MIBI accumulation related to membrane MDR protein expression in tumor cells. J Nucl Med 1998;39: 1214-8.
13. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance associated protein. Br J Cancer 1998;77:353-8.
14. Fukumoto M, Yoshida D, Kurohara A, Murata Y, Yoshida S. In vitro prediction of MDR and MRP: comparison of Tc-99m MIBI and Tc-99m tetrofosmin. J Nucl Med 1998;39(Suppl): 216.
15. Shin HJ, Lee JS, Hong WK, Shin DM. Study of multidrug resistance (mdrl) gene in non-small-cell lung cancer. Anticancer Res 1992;12:367-70.
16. Schlaifer D, Laurent G, Chittal S, Tsuruo T, Soues S, Muller C, et al. Immunohistochemical detection of multidrug resistance associated P-glycoprotein in tumour and stromal cells of human cancers. Br J Cancer 1990;62:177-82.
17. Baas F, Jongsma APM, Broxterman HJ, Arceci RJ, Housman D, Scheffer GL, et al. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Cancer Res 1990;50:5392-8.
18. Kume N, Suga K, Nishigauchi K, Kawamura M, Matsunaga N. Relationship between thallium-201 uptake and tumour proliferative ability in thyroid nodules. Eur J Nucl Med 1996; 23:376-82.
19. Ricci M, Pantano P, Pierallini A, Di Stefano D, Santoro A, Bozzao L, et al. Relationship between thallium-201 uptake by supratentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 1996;23:524-9.
20. Takekawa H, Takaoka K, Tsukamoto E, Kanegae K, Miller F, Kawakami Y. Thallium-201 single photon emission computed tomography as an indicator of prognosis for patients with lung carcinoma. Cancer 1997;80:198-203.
21. Tokuchi Y, Isobe H, Takekawa H, Hanada T, Ishida T, Ogura S, et al. Predicting chemotherapeutic response to small-cell lung cancer of platinum compounds by thallium-201 single-photon emission computerized tomography. Br J Cancer 1998;77:1363-8.
22. Fukumoto M, Yoshida S, Yoshida D, Kishimoto S. Dual-isotope SPECT of skull-base invasion of head and neck tumors. J Nucl Med 1995;36:1741-6.
23. Schwartz RB, Holman BL, Polak JF, Garada BM, Schwartz MS, Folkerth R, et al. Dual-isotope single-photon emission computerized tomography scanning in patients with glioblastoma multiforme: association with patient survival and histopathological characteristics of tumor after high-dose radiotherapy. J Neurosurg 1998;89:60-8.
24. Constantinesco A, Mertz L, Brunot B. Myocardial perfusion and function imaging at rest with simultaneous thallium-201 and technetium-99m blood-pool dual-isotope gated SPECT. J Nucl Med 1997;38:432-7.
25. Mazzanti M, Germano G, Kiat H, Kavanagh PB, Alexanderson E, Friedman JD, et al. Identification of severe and extensive coronary artery disease by automatic measurement of transient ischemic dilation of the left ventricle in dual-isotope myocardial perfusion SPECT. J Am Coll Cardiol 1996;27:1612-20.
26. Johnson LL, Seldin DW, Keller AM, Wall RM, Bhatia K, Bingham CO III, et al. Dual isotope thallium and indium antimyosin SPECT imaging to identify acute infarct patients at further ischemic risk. Circulation 1990;81:37-45.
27. Ichihara T, Ogawa K, Motomura N, Kubo A, Hashimoto S. Compton scatter compensation using the triple-energy window method for single- and dual-isotope SPECT. J Nucl Med 1993;34:2216-21.
28. Tonami N, Shuke N, Yokoyama K, Seki H, Takayama T, Kinuya S, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997-1004.
29. Nishizawa K, Okuineff P, Elmaleh D, Mckusick KA, Strauss HW, Suit HD. Blood flow of human soft tissue sarcomas measured by thallium-201 scanning: prediction of tumor response to radiation. Int J Radiat Oncol 1991;20:593-7.
30. 201Tl SPET to predict the response to radiotherapy in patients with head and neck cancer. Nucl Med Commun 1996;17:935-42.
31. Fukumoto M, Kurohara A, Yoshimura N, Yoshida D, Akagi N, Yoshida S. Relationship between ATP synthesis and thallium-201 uptake in transformed and non-transformed cell lines. Nucl Med Commun 1998;19:1169-75.
32. Hall EJ. The oxygen effect and reoxygenation. In: Hall EJ, editor. Radiology for radiologists. 4th ed. Philadelphia: J.B. Lippincott Co., 1994:133-51.
33. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br JCancer 1955;9:539-49.
34. Powers WE, Tolmach LJ. A multicomponent X ray survival curve for mouse lymphosarcoma cells irradiated in vivo. Nature 1963;197;710-1.
35. Gatenby RA, Kessler HB, Rosenblum JS, Coia LR, Moldofsky PJ, Hartz WH, et al. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 1988;14: 831-8.
36. Moulder JE, Hopwood LE, Volk DM, Davies BM. Radiation induction of drug resistance in RIF-1: correlation of tumor and cell culture results. Int J Radiat Oncol Biol Phys 1991; 20:213-6.
37. Hopwood LE, Davies BM, Moulder JE. Drug resistance following irradiation of RIF-1 tumors: influence of the interval between irradiation and drug treatment. Int J Radiat Oncol Biol Phys 1990;19:643-50.
38. Sharma RC, Schimke RT. Enhancement of the frequency of methotrexate resistance by gamma-radiation in Chinese hamster ovary and mouse 3T6 cells. Cancer Res 1989;49: 3861-6.
39. Osmak M, Perovic S. Multiple fractions of gamma rays induced resistance to cis-dichloro-diammineplatinum (II) and methotrexate in human HeLa cells. Int J Radiat Oncol Biol Phys 1989;16:1537-41.
40. Hill BT, Deuchars K, Hosking LK, Ling V, Whelan RD. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro. J Natl Cancer Inst 1990;82:607-12.
41. Habraken Y, Laval F. Enhancement of 1,3-bis(2-chloro-ethyl)-1-nitrosourea resistance by gamma-irradiation or drug pretreatment in rat hepatoma cells. Cancer Res 1991; 51:1217-20.
42. 99mTc-sestamibi SPET? Eur J Nucl Med 1998;25:401-9.
43. Ciarmiello A, Del Vecchio S, Silvestro P, Potena MI, Carriero MV, Thomas R, et al. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol 1998;16:1677-83.
44. Yamamoto Y, Nishiyama Y, Satoh K, Takashima H, Ohkawa M, Fujita J, et al. Comparative study of technetium-99m-sestamibi and thallium-201 SPECT in predicting chemotherapeutic response in small cell lung cancer. J Nncl Med 1998;39:1626-9.
45. Kapucu LO, Akyuz C, Vural G, Oguz A, Atasever T, Buyukpamukcu M, et al. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi. J Nucl Med 1997;38:243-7.
46. 99mTc-MIBI scanning in multiple myeloma. Br J Cancer 1996;74:1815-20.
47. Moretti JL, Azaloux H, Boisseron D, Kouyoumdjian JC, Vilcoq J. Primary breast cancer imaging with technetium-99m sestamibi and its relation with P-glycoprotein overexpression. Eur J Nucl Med 1996;23:980-6.
48. 99mTc-sestamibi uptake in lung cancer; relationship with clinical response to chemotherapy. Nucl Med Commun 1997;18: 1087-97.